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Abstract
Background: DNA methylation is a widespread epigenetic modification in vertebrate genomes. Genomic sites of
DNA methylation can be bound by methyl-CpG-binding domain proteins (MBDs) and specific zinc finger proteins,
which can recruit co-repressor complexes to silence transcription on targeted loci. The binding to methylated DNA
may be regulated by post-translational MBD modifications.
Findings: A methylated DNA affinity precipitation method was implemented to assay binding of proteins to
methylated DNA. Endogenous MeCP2 and MBD3 were precipitated from Xenopus oocyte extracts and conditions
for methylation-specific binding were optimized. For a reverse experiment, DNA methylation in early Xenopus
embryos was assessed by MBD affinity capture.
Conclusions: A methylated DNA affinity resin can be applied to probe for MBD activity in extracts. This assay has a
broad application potential as it can be coupled to downstream procedures such as western blotting, fluorimetric
HDAC assays and quantitative mass spectrometry. Methylated DNA affinity capture by methyl-CpG binding proteins
produces fractions highly enriched for methylated DNA, suitable for coupling to next generation sequencing
technologies. The two enrichment strategies allow probing of methyl-CpG protein interactions in early vertebrate
oocytes and embryos.
Background
DNA methylation is an epigenetic modification mostly
associated with transcriptional repression in vertebrate
genomes. In vertebrates, methylation events occur pre-
dominantly within the context of CpG dinucleotides,
which in mammals by and large are methylated [1,2].
The repressive signal inferred by DNA methylation is
further interpreted by methyl-CpG binding domain
(MBD) proteins that bind sites of DNA methylation and
can recruit complexes with histone deacetylase (HDAC)
activity to silence transcription [3-6]. The MBD was
initially described as the minimal part of the MeCP2
protein required for methylated DNA binding [7]. Four
remaining family members (MBD1, MBD2, MBD3 and
MBD4) have been discovered on the basis of homology
searches with the MeCP2 MBD amino acid sequence
[8]. In addition, several structurally unrelated methyl-
CpG binding proteins have been identified [9,10]. Muta-
tion or knockdown of DNA methyltransferases and
MBD genes result in severe developmental phenotypes
[11-14]. Mutations in the MBD family founder, MeCP2,
are the cause of Rett Syndrome (RTT), a grave neurode-
velopmental disorder which due to its X chromosome
linkage almost exclusively affects females [15,16]. In
post-mitotic neurons, the brain-derived neurotrophic
factor (BDNF) promoter III is controlled by phosphory-
lation-dependent MeCP2 binding [17,18]. Membrane
depolarization results in MeCP2 phosphorylation, car-
ried out by the CamKI kinase, which diminishes its
binding affinity for methylated DNA [19,20]. A number
of methods to study DNA-protein interactions have
been developed over the years. For example, chromatin
immunoprecipitation (ChIP) coupled to microarray
hybridization or Next-Generation Sequencing technolo-
gies has facilitated the generation of genomic maps of
transcription factor binding sites [21,22]. Other widely
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DNA footprinting, EMSA (Electrophoretic Mobility Shift
Assay), southwestern blotting (SW), DNA affinity chro-
matography and DNA-protein crosslinking in vitro
(DPC) [23,24] DNA affinity precipitation is an efficient
method for the analysis and purification of proteins dis-
playing sequence specificity for DNA [25,26]. Such
assays can be used to study binding affinity and recruit-
ment specificity of either recombinant or cellular pro-
teins [27,28]. Recently, important progress has been
made in understanding the interactions of modified his-
tone tails with transcriptional regulators [29-31]. These
studies have combined peptide affinity pull-downs and
quantitative mass spectrometry enabled by SILAC
(Stable Isotope Labeling by Amino Acids in Cell Cul-
ture) [32]. It will be of great importance to define pro-
teins recruited to methylated DNA during early
development. For over a century amphibians from the
genus Xenopus have been the organisms of choice to
study developmental processes. The main reason for this
is external embryonic development as well as the rela-
tively large size of the embryos themselves which allows
easy experimental manipulation. A number of studies
involving DNA methylation and methyl-CpG binding
proteins established Xenopus laevis as an important
model for epigenetics studies [9,33-35]. Sequencing of
the Xenopus tropicalis genome rendered this organism
suitable for (epi)genomics studies of the early vertebrate
development [36-38]. Here we describe an efficient
method for methylated DNA affinity precipitation of
MBDs from Xenopus oocytes. Using in vitro methylated
DNA oligonucleotides bound to magnetic beads and
conditions that promote methylation-specific binding,
MeCP2 and MBD3 were pulled down. These methylated
DNA affinity precipitation assays have a broad applica-
tion potential as they can be combined with a number
of biochemical techniques and used in different model
systems. Furthermore, to test the ability of MeCP2 to
affinity-precipitate methylated DNA from early Xenopus
embryos, the immobilized MBD domain of MeCP2 can
be used to enrich for methylated genomic DNA [39-41].
The fractions enriched for methylated DNA, due to
their high recovery rate, are suitable for coupling to
next generation sequencing technologies.
Methods
Oocyte extract preparation
Xenopus laevis oocytes were collected in an eppendorf
tube and homogenized in ice cold lysis buffer (20 mM
Tris (pH = 8,0), 70 mM KCl, 1 mM EDTA, 10% gly-
cerol, 5 mM DTT, 0,125% NP40, Roche Complete pro-
tease inhibitors). The extract was centrifuged for 5
minutes at 4°C at maximum speed. The supernatant was
collected and quick-frozen in liquid nitrogen. The final
oocyte concentration in the extract was 0.5 oocyte
equivalents per μL assuming that one oocyte corre-
sponds to 1 μL.
MeCP2-MBD in vitro transcription and translation
The pT7TS-5’M B Dc o n s t r u c t ,e n c o d i n gt h ef i r s t1 7 6
amino acids of Xenopus laevis MeCP2, was obtained by
PCR amplification (primers 5’-gtatccgtcgacaattcggcacga-
gagaaaATG and 5’-acaagaggatcctcaGGCTTTCGGT
TGCTTCTGTTCC), digestion of the PCR product with
SalI and BamH1, blunting and ligation in the EcoRV site
of pT7TS. In vitro transcription of the pT7TS-5’MBD
was performed using the mMESSAGE mMACHINE T7
kit (Ambion). The in vitro translation was achieved
using 1 μg of RNA in a total volume of 50 μL( F l e x i
Rabbit, Promega). The binding assay was performed in
150 μLA B C Db u f f e r2 0m MT r i s( p H=8 , 0 ) ,1m M
EDTA, 5 mM DTT, 5 mM MgCl2, 100 mM KCl,
0,125% NP40, protease inhibitors) with 6 μLo ft h ein
vitro translation reaction, using the protocol described
below.
DNA affinity precipitation
T h eD N Ap r o b ew a so b t a i n e db ya n n e a l i n go f5 0μgo f
two complementary oligonucleotides (5’-GATCCCG-
GAGTTAA and 5’-GATCTTAACTCCGG), modified
from Klose et al. [42]. The annealed probe was phos-
phorylated with T4 polynucleotide kinase (New England
Biolabs) for 2 h at 37°C, purified by phenol-chloro-
phorm and precipitated with ethanol. The concatameri-
zation reaction was performed at RT for 4 h with T4
ligase (Promega) in the presence of 10 mM ATP to
replenish the ATP from the ligase buffer. The ligation
process was monitored using 1% agarose gel electro-
phoresis. The reaction was ethanol precipitated for one
hour at -20°C. After DNA precipitation, two biotinylated
nucleotides, biotin-16-dUTP and biotin-14-dATP were
used to fill in the overhangs in a polymerization reaction
using the Klenow fragment (New England Biolabs). All
the nucleotides in the reaction were present at a con-
centration of 0.1 mM. The reaction was allowed to pro-
ceed for 45 minutes at room temperature. The
biotinylated DNA was then purified using a gel extrac-
tion kit (Qiagen) and the samples were recovered in 30
μl elution buffer. The biotinylated oligos (~50 μg) were
methylated with SssI methyltransferase in a 500 μlr e a c -
tion for 2 h at 37°C. Phenol-chlorophorm extraction was
used to clean the methylated DNA which was then pre-
cipitated by ethanol. The methylated probe was then
coupled to streptavidin beads (DYNA beads M-280). For
each 3 μgo fD N A ,3 0μl of the streptavidin beads was
used. The beads were washed 3X with the WB (1 M
NaCl, 20 mM Tris pH 8.0, 1 mM EDTA) buffer. After
washing, 3 μg of the methylated probe (10 μl) was
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WB buffer, 10 μl were separated for subsequent gel ana-
lysis while the remaining 40 μL was added to streptavi-
din beads. The mixture was incubated on a
thermomixer set at 30°C for 30 minutes with shaking.
Oocyte extracts (100 μL) were coupled to the immobi-
lized probe in affinity precipitation (AP) buffer (20 mM
Tris pH 8.0, 1 mM EDTA, 5 mM DTT, 5 mM MgCl2,
100 mM KCl, 0.125% NP40, protease inhibitors) in a 1:1
ratio and left rotating over night at 4°C. After incubation
the mixtures were washed with washing buffer (20 mM
Tris (pH = 8,0), 1 mM EDTA, 5 mM DTT, 5 mM
MgCl2, 100-200 mM KCl, 0,125% NP40, protease inhibi-
tors) for three times and the bound fraction was eluted
with 50 μL 1X Laemmli sample buffer and analyzed by
western blotting.
Western blotting
The eluate (25 μl) was resolved on 10% polyacrylamide
gels and subjected to western blotting. The a-MeCP2
antibody (V17-1) was raised against the C-terminal pep-
tide MeCP2 peptide of Xenopus laevis (PRPTRE
EPVDTRTT). The final serum was affinity purified and
used in a 1:1000 dilution. The ISWI, Mi-2 and MBD3
antibodies have been described before [5,43,44]. The
western blotting protocol was performed as described
before [45].
Genomic DNA isolation and sonication
Xenopus tropicalis embryos (n = 50) were homogenized
in 625 μL (12.5 μl/embryo) of homogenization buffer
(20 mM Tris pH 8.0, 100 mM NaCl, 15 mM EDTA, 1%
SDS, 0.5 mg/ml proteinase K). The homogenate was
then incubated for 3 h at 55°C. The tubes were gently
inverted after every hour of incubation. Two Phenol/
Chlorophorm/Isoamylalcohol (25:24:1, PCI) extractions
were performed using the same amount (625 μL) of PCI
and inverting the tubes gently. The samples were spun
for 5 minutes at 13000 rpm in a table-top centrifuge fol-
lowing every PCI extraction. The DNA was precipitated
by adding 1/5 volume of 4 M NH4Ac and 3 volumes of
cold 96% ethanol and left on ice for 1 h. The DNA pre-
cipitate was then centrifuged for 20 minutes at 4°C and
13,000 rpm in a table-top centrifuge. The pellet was
washed with 500 μL of 70% ethanol and centrifuged for
5 minutes, 13,000 rpm at RT. The pellet was then resus-
pended in 200 μL of TE buffer with 1 μlo fR N A s eA
(20 μg/μl) and left at RT for 30 minutes. The reaction
was precipitated with 0.1 volumes of 4 M NH4Ac and 1
volume of isopropanol on ice for 1 h. The precipitate
was centrifuged for 20 minutes at 4°C at maximum
speed in a table-top centrifuge and washed with 70%
ethanol. The pellet was resuspended in 100 μlo f
DNAse/RNAse free water. Two samples consisting of 50
embryo equivalents were pulled together to obtain a 200
μl sample with a concentration of ~ 0.1 μg/μL. The
sample was sonicated for 15 minutes (13 seconds on, 16
seconds off, maximum output) in a Bioruptor (Diage-
node) device.
Methylated DNA affinity capture (MethylCap)
Genomic DNA was sheared by sonication to ~ 500 bp
fragments. Methylated DNA was affinity purified using
the H6-GST-MBD fusion protein (Diagenode) following
the manufacturers’ protocol with one modification. The
DNA was eluted in several steps with increasing NaCl
concentrations (150 μl ) :2×2 0 0m M ,1×3 0 0m M ,1×
500 mM, 1 × 600 mM and 1 × 700 mM. The recovery
of methylated DNA from six genomic targets was calcu-
lated by quantitative PCR, whereas the concentration of
DNA in each eluate was obtained by Picogreen
measurement.
Results
Immobilized DNA preparation
To study the binding affinities of MBDs in Xenopus,
small-scale DNA affinity precipitation was applied using
t h es e q u e n c eG A T C - C CGG-AGTTAA which features a
single CpG dinucleotide [42]. A probe containing 11
CpG dinucleotides (6(GAC)-CCGG-6(GAC)) yielded
similar results but proved more difficult to concatamer-
ize, probably due to high CpG density of the fragment.
The double-stranded oligonucleotide was methylated,
concatamerized, immobilized and incubated with oocyte
extracts (Figure 1A). After performing the washing steps,
the proteins that bind methylated DNA were eluted. Per-
forming the same experiment in parallel with an
unmethylated oligonucleotide is a necessary control
ensuring the binding occurs due to template DNA
methylation and not sequence specificity alone. Following
annealing and phosphorylation, the probes were concata-
merized. Concatamerization is an essential step as DNA
may be degraded by the exonucleases present in oocyte
extracts. The concatamers ranged in size from 100 bp -
1000 bp with the majority falling between 100 - 300 bp
(Figure 1B). To improve the concatamerization, a second
round of phosphorylation and ligation may be performed.
Concatamerized probes were then labeled with two bioti-
nylated nucleotides (biotin-16-dUTP and biotin-14-
dATP) to ensure the maximum binding efficiency in a
Klenow fill-in reaction. Following biotinylation, the
probes were in vitro methylated by the SssI enzyme. The
extent of the methylation reaction was examined by
MspI and HpaII digestion (Figure 1C). Such a digestion
reaction should be performed to ensure that the probe is
efficiently methylated and the concatamerization worked
properly. High molar concentrations of oligos during the
ligation reaction might induce concatamerization
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MspI enzyme. Following the in vitro methylation reaction
the probe was coupled to streptavidin beads. After incu-
bation, 10 μl of the binding reaction was compared to 10
μl of the input by 1% agarose gel electrophoresis (Figure
1D). Immobilized DNA templates coupled to streptavidin
beads can be kept at 4°C in the same buffer used in the
washing and binding steps.
Binding of the in vitro translated MBD domain to
immobilized templates
To test whether the templates have assembled properly
and whether the system is functional, radiolabelled (
35S)
MeCP2-MBD (containing amino acids 1-176 of MeCP2)
and TBP2 (negative control) [46] were generated by in
vitro translation using the rabbit reticulocyte lysate sys-
tem. The binding occurred in the affinity precipitation
buffer at 4°C. The reaction was assembled and left over-
night on a rotating platform. The following day, 10% of
the input and 50% of the eluate of the binding reaction
were loaded on a 10% polyacrylamide gel (Figure 2A).
After exposure the visible bands were quantified using
the Image-quant software (Figure 2B). A high specificity
for DNA methylation-specific binding was observed; ~
40% of the MBD domain was recovered from the
methylated probes while the recovery from the non-
methylated control was below 3%. TBP2 displays very
low affinity (< 1% recovery) for the methylated template
whereas the binding to the unmethylated template was
in the order of ~4%.
CH3 CH3 CH3 CH3
or
concatamerized probe                oocyte extract                      methylation-specific binding
CH3 CH3 CH3 CH3
+
M
p
r
o
b
e
HpaII MspI M
100 bp
500 bp
1000 bp
B A
A
BCD
100 bp
500 bp
Figure 1 Methylated DNA affinity precipitation. (A) A methylated, concatamerized oligo is incubated with oocyte extract to probe for
proteins with methyl-CpG binding activity. After performing the necessary washing steps, the eluate contains proteins specifically binding
methylated DNA. (B) The concatamerization of the oligo is monitored by agarose gel electrophoresis. The majority of concatamerized DNA
consists of fragments ranging in size from 100 - 300 bp. (C) The extent of oligo methylation is measured by restriction digestion. MspI enzyme
cuts both methylated and unmethylated DNA whereas its isoschizomer HpaII cuts only unmethylated DNA. (D) The binding of the biotinylated
oligo to streptavidin beads is measured by agarose electrophoresis. An aliquot of the probe before incubation with streptavidin beads (before -
B) is compared to a probe aliquot after 30 minutes of incubation time (after - A).
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To optimize washing and elution conditions, the pro-
tein-DNA complexes formed during an overnight incu-
bation of oocyte extracts and immobilized probes,
were washed with increasing concentrations (100/200/
400 mM) of KCl and eluted with Laemmli buffer.
Once eluted with Laemmli buffer, the samples were
spun down to separate the beads from the supernatant
and the eluate was loaded on SDS-PAGE gel. Western
blot analysis revealed strong preference for methylated
DNA binding of both MBD3 and MeCP2 (Figure 2C-
D). The mammalian MBD3 is not able to bind methy-
lated DNA due to an insertion in the MBD. Xenopus
MBD3, however, is present in a short and a long form,
the former of which is able to specifically bind methy-
lated CpGs [5,47]. Whereas MeCP2 tolerates 200 mM
KCl in the washing buffer, most of MBD3 is eluted at
such conditions (Figure 2C). MeCP2 and the short
MeCP2
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      SssI     +         -        +         -       +         -
100 mM 200 mM 400 mM
ISWI
TFIIB
SssI + SssI - ooc
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A
C
E
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 SssI +      SssI -        SssI +      SssI -
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e
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o
v
e
r
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(
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u
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Figure 2 DNA affinity precipitation of recombinant and endogenous oocyte extracts proteins. (A) In vitro translated, S
35 labeled MBD
domain of MeCP2 specifically binds the methylated immobilized probe (SssI+). Conversely, the negative control (TBP2) displays only residual
affinity for non-methylated DNA (SssI-). (B) Quantification of DNA methylation-specific binding using the Image-quant software. ~35% of the
recombinant MBD domain is recovered after washing and elution from methylated DNA oligos. (C) Western blotting of eluates obtained after
100 mM, 200 mM and 400 mM KCl washes. MeCP2 tolerates 100 mM and 200 mM KCl concentration in the washing buffer whereas most of the
MBD3 is eluted with 200 mM salt. (D) DNA affinity precipitation of MBD3, MeCP2 and Mi-2 from oocyte extracts. MeCP2 displays strong
preference for methylated DNA, whereas Mi-2 and MBD3 bind both methylated and unmethylated DNA. The short form of MBD3, however,
displays a preference for methylated DNA. (E) Establishment of positive (ISWI) and negative (TFIIB) controls for DNA affinity precipitation.
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lated DNA (Figure 2D), in contrast to Mi-2 which can
bind both methylated and unmethylated DNA. MBD3
and Mi-2 form part of the same complex [5]; the dif-
f e r e n c ei nb i n d i n gm a yb ee x p l a i n e db yav a r i a b l e
composition of the Mi-2/NuRD complex [48-50] and
methylation-independent binding of DNA by the Mi-2/
NuRD subunit MTA1 [5]. Finally, a negative control
for DNA methylation pull-downs was established. Any
endogenous protein that does not bind directly to
DNA might serve as a negative control in these assays.
TFIIB is one of the general transcription factors
involved in RNA Polymerase II pre-initiation complex
formation [51]. Our assays identified it as a suitable
negative control as it does not bind immobilized oligo
templates independent of their methylation status (Fig-
ure 2E). In the same experiment we also tested the
binding of ISWI, another evolutionarily conserved
ATP-dependent chromatin binding protein and estab-
lished its uniform binding to methylated and unmethy-
lated DNA [44,52] Altogether, these results establish
Xenopus oocytes as an efficient system to probe for
interactions of methylated DNA and proteins with
methyl-CpG binding activity. Furthermore, we provide
a number of controls that can be used in such assays
to control for unspecific protein-DNA interactions.
Methylated DNA affinity capture (MethylCap)
A number of techniques to study DNA methylation on a
genomic scale have been developed through the last
decade. These include: Methylated DNA immunopreci-
pitation (MeDIP) [53-55], bisulfite sequencing [56,57]
and methylated DNA affinity capture (MethylCap)
[38,41,58]. These methods can be coupled to next gen-
eration sequencing technologies to identify the sites of
genomic DNA methylation [40]. MethylCap is an affi-
nity-based technique in which the immobilized methyl-
CpG binding domain of one of the MBDs is used to
capture fragments of methylated DNA [39,41,59,60] In
order to obtain pure genomic DNA in sufficient quanti-
ties for the MethylCap assay, a genomic DNA isolation
protocol has been optimized for Xenopus embryos (see
materials and methods). This protocol yields > 1 μgo f
genomic DNA from ~100 late blastula/gastrula Xenopus
tropicalis embryos (Figure 3A). In order to ensure
proper resolution of the methylated DNA affinity cap-
ture, genomic DNA has to be sonicated to small frag-
ments (200 - 300 bp). Xenopus genomic DNA samples
were sonicated using a Bioruptor (Diagenode) device
and sonicated genomic DNA was saved after five or fif-
teen minutes of sonication. The samples were then
resolved on a 1% agarose gel (Figure 3B). Fifteen min-
utes of sonication (total volume = 200 μL, concentration
=0 , 1μg/μl) yields fragments of 200 - 300 bp. Sonicated
genomic DNA was then bound to magnetic beads
coated with the MeCP2 MBD domain (Figure 3C) and
increasing NaCl concentrations were used to wash and
elute the bound methylated DNA fragments. The recov-
ery of methylated DNA was measured by quantitative
PCR. The primers used to amplify affinity-precipitated
fragments of genomic DNA correspond to DNA methy-
lation-positive (tcea, tfcp2, gs17) and methylation-nega-
tive (Xbra, trim33, hes4) loci (Figure 3B). These
genomic targets were validated by methylated DNA
immunoprecipitation (MeDIP) (Figure 3E). Genomic tar-
gets tcea, tfcp2 and gs17 are found positive for DNA
methylation by both MeDIP and MethylCap. In line
with benchmark studies [40,41] the methylation status
of the DNA fragments captured with this technique can
be confirmed by bisulfite sequencing [38]. The majority
of methylated fragments elute at high molar concentra-
tions of NaCl (500 mM, 700 mM) whereas the non-
methylated fragments are washed out at 200 mM,
demonstrating the specific methylated-CpG affinity of
the MBD resin (Figure 3B). Furthermore, to measure
the amount of DNA captured in such an approach, frac-
tions eluted at 500 mM, 600 mM and 700 mM NaCl,
were subjected to Picogreen measurement. All the
examined fractions had a concentration of > 1 ng/μl
(data not shown) making them highly suitable for next
generation sequencing library preparation. Taken
together, these results demonstrate an efficient approach
to study DNA methylation in early vertebrate embryos.
Discussion
In this study we describe an efficient method for the
pull-down of DNA methylation-specific proteins from
Xenopus oocyte extracts. Furthermore, we demonstrate
the functionality of this system by specifically pulling
down two major Xenopus methyl-CpG binding proteins.
In addition, we assay the ability of the methyl-CpG
binding domain of MeCP2 to affinity-capture methy-
lated genomic DNA and establish conditions that result
in the elution of methylated fractions. Using methylated
DNA affinity precipitation, MeCP2 and MBD3 were
pulled down from Xenopus oocytes and positive as well
as negative controls for this approach were established.
The chromatin remodelers Mi-2 and ISWI can be used
as loading controls and TFIIB as a negative control.
Methylated DNA affinity precipitation is a valuable tech-
nique that can be coupled to western blotting or HDAC
assays in order to assess the composition of bound frac-
tions. Also, a great potential lies in combining methy-
lated DNA pull-downs with mass spectrometry
approaches to aid the identification of proteins with
DNA methylation-specific binding. A number of recent
studies demonstrated the importance of similar applica-
tions in identifying novel chromatin components in
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Figure 3 Genomic DNA isolation and sonication. (A) Xenopus tropicalis genomic DNA isolated from blastula (bl) and gastrula (ga) embryos.
(B) Genomic DNA analyzed after 5 minutes or 15 minutes of sonication. Genomic DNA sonicated for 15 minutes yields fragments of 100 - 300
bp. (C) A schematic representation of methylated DNA affinity capture (MethylCap). Methylated DNA is bound by the immobilized methyl-CpG
binding domain of MeCP2, washed and eluted with increasing NaCl concentrations. (D) PCR quantitation of methylated DNA recovery. DNA
methylation targets (tcea, tfcp2 and gs17) mostly elute at high NaCl concentrations (500 mM, 600 mM and 700 mM) whereas the non-
methylated targets (Xbra, trim33, hes4) are washed out with the first washing step (200 mM). (E) The methylation status of genomic targets tcea,
tfcp2, gs17, trim33 and hes4 was validated by MeDIP (methylated DNA immunoprecipitation). The error bars represent standard deviation (SD) of
two experiments.
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binding proteins in vertebrate oocytes/embryos has not
yet been established. For example, in brain extracts,
MeCP2 is known to be actively regulated by serine
phosphorylation which diminishes its DNA binding affi-
nity and enables the proper neural response [17,19]. It is
possible that during early embryogenesis similar phos-
phorylation events, which result in altered binding affi-
nity, take place. Also, MBD proteins are known to
interact with a plethora of proteins and most of these
interactions are dependent on the biological context
[61]. Methylated DNA affinity precipitation coupled to
mass spectrometry might help in identifying the nature
of these interactions in the developing embryo. To cap-
ture methylated DNA, genomic DNA isolated from
early Xenopus embryos was incubated with an MBD affi-
nity resin and eluted with increasing salt concentrations.
The fractions eluted at concentrations of 500 - 700 mM
NaCl contain fragments of highly methylated DNA
[38,40,41]. On the other hand, the majority of non-
methylated fragments that were non-specifically bound
to the resin already elute with 200 mM NaCl. The rela-
tively high concentration of DNA in the fractions ren-
ders this method highly suitable for coupling to next
generation sequencing technologies.
Conclusions
Binding of MBDs to sites of genomic DNA methylation
is a biologically important process that modulates the
transcriptional output of the cell. It is therefore essential
to have suitable assays to probe for this kind of interac-
tions. Together, the two affinity-capture based assays
discussed above, allow for unbiased profiling of methy-
lated DNA-binding proteins and the genomic loci they
may target, setting the stage for a new and exciting era
of quantitative profiling in early vertebrate embryos.
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